jimnyc
12-11-2020, 07:46 PM
I've already read about some horrible covid-like symptoms when you get this vaccine. I even read one out of the UK about folks going into anaphylactic shock.
At the same time, they all have over 90%+ success rate. Up to 95% for at least 2 of them.
As I said, it starts with front line workers and elderly in nursing homes, sick patients... and so on downward. Gonna be awhile, I believe, before it gets to healthy folks, I dunno.
---
FDA Panel Gives Emergency Approval to Pfizer COVID Vaccine
The Vaccines and Related Biological Products Advisory Committee of the Food and Drug Administration recommended that the agency give approval to Pfizer to start distributing their coronavirus vaccine throughout the United States. The FDA could decide as early as Friday to give the go-ahead on vaccine distribution, ending a remarkable process that brought a vital vaccine from concept to market in about eight months.
It’s a process that usually takes 3-5 years, but with billions of dollars from the government being poured into vaccine development at several different companies, the odds were pretty good that there would be a quick breakthrough.
Trials are ongoing and not everyone will be able to get a shot. The agency is expected to approve use for those over the age of 16 except for women who are pregnant. Testing on those specific groups continues.
CNBC:
It’s unclear whether the FDA will authorize Pfizer and BioNTech’s vaccine for use in certain groups. Some people, including pregnant women and young children, will likely have to wait to get the vaccine in the U.S. until Pfizer can finish trials on those specific groups. The FDA said Tuesday that there is currently insufficient data to make conclusions about the safety of the vaccine in children under age 16, pregnant women and people with compromised immune systems. Regulators in Canada, the U.K. and Bahrain have all cleared the vaccine for use by most adults.
The committee recommended emergency authorization of the vaccine for people who are 16 years old and older. Prior to the vote, some experts in the meeting argued to limit its recommendation to people who are at least 18, saying the safety data on 16- and 17-year olds was “thin.”
Rest - https://pjmedia.com/news-and-politics/rick-moran/2020/12/11/fda-panel-gives-emergency-approval-to-pfizer-covid-vaccine-n1204141
Apparently not a fatal reaction type - but enough that they are warning folks with such reactions allergies to not get the shot. What they do then is beyond me.
Allergy risk on Pfizer jab: Day before FDA meet to give green light to vaccine UK regulators warn people with 'significant' food and medicine allergies NOT to take it after two health workers suffer 'anaphylactic reaction'
Two British healthcare workers who got the vaccine on Tuesday have had allergic reactions
They are both now recovering well but British regulators are warning people with 'severe' food and medicine allergies not to get it yet as a precaution
FDA regulators are meant to meet on Thursday to approve the vaccine for the US
It comes after widespread outrage that the UK approved it before America did
During its trial phase, 137 of the 20,000 who got the vaccine had allergic reactions
But 111 people among the 20,000 who were given a placebo also had allergic reactions which made scientists dismiss it
The soonest the US could start giving out doses is December 15 - just six days away
It will not become widespread until mid March or April
There are fears over how safe Pfizer's COVID vaccine is after two British healthcare workers who were among the first in the world to receive it on Tuesday went into anaphylactic shock hours later, prompting British authorities to tell anyone with a 'severe' allergy to food or medicine not to get it.
The FDA is due to meet tomorrow to discuss green-lighting the vaccine in America after being lambasted for taking a week longer than the Brits to get it off the ground.
As of Tuesday, more than 15million people in the US had been diagnosed with COVID and the total number of deaths since the start of the pandemic reached more than 284,000. That number is expected to climb as a result of Thanksgiving travel and gatherings.
In a preliminary analysis posted online on Tuesday, one group of FDA scientists said it was safe.
Among the 20,000 people who were given the vaccine in Pfizer's global trial, 137 had allergic reactions but so did 111 people who were given the placebo, leading scientists to dismiss it as a potential hazard.
Rest - https://www.dailymail.co.uk/news/article-9034479/Allergy-risk-Pfizer-jab-ahead-key-FDA-meeting-tomorrow.html
People with anaphylaxis history should not take Pfizer COVID shot
British regulator issues new guidance after adverse reactions in small number of people with previous allergies.
The UK’s medicine regulator says anyone with a history of anaphylaxis to a medicine or food should not get the Pfizer-BioNTech vaccine, expanding its guidance on an earlier allergy warning about the shot, the first against COVID-19 to have secured approval.
“Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer BioNTech vaccine,” June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA) said in a statement. “A second dose should not be given to anyone who has experienced anaphylaxis following administration of the first dose of this vaccine.”
Rest - https://www.aljazeera.com/news/2020/12/10/people-with-anaphylaxis-history-should-not-take-pfizer-covid-shot
At the same time, they all have over 90%+ success rate. Up to 95% for at least 2 of them.
As I said, it starts with front line workers and elderly in nursing homes, sick patients... and so on downward. Gonna be awhile, I believe, before it gets to healthy folks, I dunno.
---
FDA Panel Gives Emergency Approval to Pfizer COVID Vaccine
The Vaccines and Related Biological Products Advisory Committee of the Food and Drug Administration recommended that the agency give approval to Pfizer to start distributing their coronavirus vaccine throughout the United States. The FDA could decide as early as Friday to give the go-ahead on vaccine distribution, ending a remarkable process that brought a vital vaccine from concept to market in about eight months.
It’s a process that usually takes 3-5 years, but with billions of dollars from the government being poured into vaccine development at several different companies, the odds were pretty good that there would be a quick breakthrough.
Trials are ongoing and not everyone will be able to get a shot. The agency is expected to approve use for those over the age of 16 except for women who are pregnant. Testing on those specific groups continues.
CNBC:
It’s unclear whether the FDA will authorize Pfizer and BioNTech’s vaccine for use in certain groups. Some people, including pregnant women and young children, will likely have to wait to get the vaccine in the U.S. until Pfizer can finish trials on those specific groups. The FDA said Tuesday that there is currently insufficient data to make conclusions about the safety of the vaccine in children under age 16, pregnant women and people with compromised immune systems. Regulators in Canada, the U.K. and Bahrain have all cleared the vaccine for use by most adults.
The committee recommended emergency authorization of the vaccine for people who are 16 years old and older. Prior to the vote, some experts in the meeting argued to limit its recommendation to people who are at least 18, saying the safety data on 16- and 17-year olds was “thin.”
Rest - https://pjmedia.com/news-and-politics/rick-moran/2020/12/11/fda-panel-gives-emergency-approval-to-pfizer-covid-vaccine-n1204141
Apparently not a fatal reaction type - but enough that they are warning folks with such reactions allergies to not get the shot. What they do then is beyond me.
Allergy risk on Pfizer jab: Day before FDA meet to give green light to vaccine UK regulators warn people with 'significant' food and medicine allergies NOT to take it after two health workers suffer 'anaphylactic reaction'
Two British healthcare workers who got the vaccine on Tuesday have had allergic reactions
They are both now recovering well but British regulators are warning people with 'severe' food and medicine allergies not to get it yet as a precaution
FDA regulators are meant to meet on Thursday to approve the vaccine for the US
It comes after widespread outrage that the UK approved it before America did
During its trial phase, 137 of the 20,000 who got the vaccine had allergic reactions
But 111 people among the 20,000 who were given a placebo also had allergic reactions which made scientists dismiss it
The soonest the US could start giving out doses is December 15 - just six days away
It will not become widespread until mid March or April
There are fears over how safe Pfizer's COVID vaccine is after two British healthcare workers who were among the first in the world to receive it on Tuesday went into anaphylactic shock hours later, prompting British authorities to tell anyone with a 'severe' allergy to food or medicine not to get it.
The FDA is due to meet tomorrow to discuss green-lighting the vaccine in America after being lambasted for taking a week longer than the Brits to get it off the ground.
As of Tuesday, more than 15million people in the US had been diagnosed with COVID and the total number of deaths since the start of the pandemic reached more than 284,000. That number is expected to climb as a result of Thanksgiving travel and gatherings.
In a preliminary analysis posted online on Tuesday, one group of FDA scientists said it was safe.
Among the 20,000 people who were given the vaccine in Pfizer's global trial, 137 had allergic reactions but so did 111 people who were given the placebo, leading scientists to dismiss it as a potential hazard.
Rest - https://www.dailymail.co.uk/news/article-9034479/Allergy-risk-Pfizer-jab-ahead-key-FDA-meeting-tomorrow.html
People with anaphylaxis history should not take Pfizer COVID shot
British regulator issues new guidance after adverse reactions in small number of people with previous allergies.
The UK’s medicine regulator says anyone with a history of anaphylaxis to a medicine or food should not get the Pfizer-BioNTech vaccine, expanding its guidance on an earlier allergy warning about the shot, the first against COVID-19 to have secured approval.
“Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer BioNTech vaccine,” June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA) said in a statement. “A second dose should not be given to anyone who has experienced anaphylaxis following administration of the first dose of this vaccine.”
Rest - https://www.aljazeera.com/news/2020/12/10/people-with-anaphylaxis-history-should-not-take-pfizer-covid-shot